↓ Skip to main content

Cochrane Database of Systematic Reviews

Sertindole for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, July 2005
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

policy
1 policy source
twitter
5 tweeters
weibo
1 weibo user
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
138 Mendeley
Title
Sertindole for schizophrenia
Published in
Cochrane database of systematic reviews, July 2005
DOI 10.1002/14651858.cd001715.pub2
Pubmed ID
Authors

Ruth Lewis, Anne-Marie Bagnall, Maria Leitner

Abstract

Sertindole is an atypical antipsychotic, which is thought to give a lower incidence of extrapyramidal side effects at clinically effective doses than typical antipsychotic drugs. In December 1998, Lundbeck Ltd., the manufacturers of sertindole, voluntarily suspended the availability of the drug due to concerns about cardiac arrhythmia and sudden cardiac death associated with its use. However, based on the advice of an appointed expert group, the Committee for Proprietary Medicinal Products (CPMP) lifted the suspension of sertindole in October 2001, a decision that was ratified by the European Commission on the 26th of June 2002. Lundbeck have committed to the CPMP to carry out two post-marketing surveillance (PMS) studies (which were initiated in July 2002) to provide additional epidemiological data under conditions of normal drug usage. Initial marketing of the product will be restricted and Lundbeck is currently in discussions with the US health authorities (FDA) to investigate whether, and if so when, it would be possible to launch Serdolect in the US market.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 138 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 1%
Spain 1 <1%
Finland 1 <1%
Unknown 134 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 14%
Student > Master 19 14%
Student > Ph. D. Student 16 12%
Student > Bachelor 13 9%
Student > Doctoral Student 11 8%
Other 31 22%
Unknown 28 20%
Readers by discipline Count As %
Medicine and Dentistry 58 42%
Psychology 18 13%
Nursing and Health Professions 8 6%
Social Sciences 5 4%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Other 12 9%
Unknown 32 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 May 2017.
All research outputs
#2,074,925
of 15,827,677 outputs
Outputs from Cochrane database of systematic reviews
#4,792
of 11,293 outputs
Outputs of similar age
#23,812
of 168,610 outputs
Outputs of similar age from Cochrane database of systematic reviews
#41
of 113 outputs
Altmetric has tracked 15,827,677 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,293 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.5. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,610 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 113 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.